论文部分内容阅读
目的探讨布地奈德、可必特联合治疗慢阻肺急性发作的临床疗效.方法选取本院2010年2月到2011年2月期间本院收治的慢阻肺急性发作患者122例,随机分成观察组61例,对照组61例,给予对照组可必特治疗,给予观察组布地奈德联合可必特治疗,比较两组患者的临床疗效.结果对照组治疗前生活质量评分为(61.21±6.53)分,治疗后生活质量评分(47.43±7.38)分,住院时间(18.87±4.21)日;观察组治疗前生活质量评分为(60.98±7.21)分,治疗后生活质量评分(44.35±6.58)分,住院时间(14.32±3.83)日.两组患者在治疗后生活质量评分和住院时间方面具有显著性差异,P<0.05,有统计学意义.结论布地奈德、可必特联合治疗慢阻肺急性发作具有确切的临床疗效,值得临床推广使用.“,”Objective: To investigate the effects of budesonide, combivent combined treatment of COPD acute clinical efficacy. Method: to select this hospital from 2010 February to 2011 February were treated in our hospital during the period of chronic obstructive pulmonary disease patients with acute onset in 122 cases, 61 cases were randomly divided into the observation group, 61 cases in the control group, the control group given combivent in the treatment group, to give observation of budesonide combined with combivent in the treatment, comparing the two groups of patients with clinical efficacy. Results: in the control group before treatment quality of life score was (61.21± 6.53), after treatment and quality of life score (47.43±7.38), (18.87±4.21) hospitalized time of day; observation group before treatment quality of life score was (60.98± 7.21), after treatment and quality of life score (44.35±6.58) branch, hospitalization time (14.32±3.83) days. Two groups of patients after treatment quality of life score and length of hospital stay have significant difference, P<0.05, with statistical significance. Conclusion: budesonide, combivent combined treatment of COPD acute episode has exact curative effect, it is worth for clinical use.